Outlook Therapeutics Inc (OTLK)

Outlook Therapeutics Inc Stock (OTLK) Financials Data

*All numbers in millions

Period End Date	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30
Period Length	3 Months	3 Months	3 Months	3 Months	3 Months
Cost Of Revenue	88.64%0.02	0.15	0.03	0.92	0.44
Gross Profit	62.24%-0.01	-0.02	-1.24	-1.01	1.07
	20.56%7.55	9.50	-	-	-
Selling, General, and Administrative	20.56%7.55	9.50	-	-	-
Research and Development	27.76%3.25	4.50	-	-	-
Depreciation and Amortization	54.66%0.01	0.03	0.03	0.03	0.03
Operating Income/Loss	22.93%-10.81	-14.03	-13.48	-17.31	-15.75
Net Interest Income/Expense	133.33%0.00	0.00	-	-0.26	-0.05
Income/Loss From Equity Method Investments	9.10%-0.04	-0.05	-0.04	-0.04	-0.03
Income/Loss From Continuing Operations Before Tax	356.30%-20.32	-4.45	-23.06	-14.85	-20.15
	356.30%-20.32	-4.45	-23.06	-13.29	-20.15
Attributable To Parent	356.30%-20.32	-4.45	-23.06	-13.29	-20.15
Available To Common Stockholders, Basic	356.30%-20.32	-4.45	-23.06	-13.29	-20.15
Basic Average Shares	67.09%136.74	81.84	60.21	4.13	36.96
Diluted Average Shares	67.09%136.74	81.84	60.21	4.13	36.96
Basic Earnings Per Share	200.00%-0.15	-0.05	-0.38	-0.19	-0.55
Diluted Earnings Per Share	200.00%-0.15	-0.05	-0.38	-0.19	-0.55